Back

Long-term adherence to secondary preventive medications after myocardial infarction: a post-hoc analysis of the BETAMI trial

30 August 2026 (17:15 - 17:45)
Organised by: Logo
Congress Presentation Part of: Innovative therapeutic strategies in coronary artery disease Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Arnhild Bakken

Oslo University Hospital Ulleval, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
Spinal Cord Stimulation in patients with Refractory Angina Pectoris (SCRAP); double-blind, placebo-controlled, cross-over randomized controlled trial
Miss F. Vervaat (Eindhoven, NL)
Abstract
Presentation thumbnail
The effects of STAtin-FENOfibrate combination therapy vs. statin monotherapy on necrotic core and plaque characteristics in non-diabetic patients with combined dyslipidemia and intermediate CAOD
Professor S. Han (Incheon, KR)
Abstract
Presentation thumbnail
Safety and efficacy of coronary sinus narrowing for treating refractory angina in real-world setting - single center experience
Ms J. Grygier (Poznan, PL)
Abstract
Presentation thumbnail
Natriuretic peptides reverse vascular insulin resistance and supress insulin-induced mechanisms of atherogenesis
Doctor D. Foran (Oxford, GB)
Abstract

Access the full session

Session thumbnail
Innovative therapeutic strategies in coronary artery disease

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Adherence and persistence of optimal medical therapy after myocardial infarction in a low to middle income country
13 March 2021
thumbnail
Congress Presentation
Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy.
27 August 2021
thumbnail
Congress Presentation
The effect of arrhyhthmia monitoring in post-MI patients: post-hoc analyses of the BIO-GUARD-MI trial
14 April 2026
thumbnail
Congress Presentation
High rates of discontinuation and reinitiation of secondary preventive medications after a first myocardial infarction
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources